Back
BioXcel Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
31
BTAI
BioXcel Therapeutics
Last Price:
$2.10
Seasonality Move:
-32.95%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BTAI is experiencing slight buying pressure.
BioXcel Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.97 | Buy |
20-day SMA: | 1.85 | Buy |
50-day SMA: | 1.66 | Buy |
200-day SMA: | 4.62 | Sell |
8-day EMA: | 1.97 | Buy |
20-day EMA: | 1.87 | Buy |
50-day EMA: | 1.85 | Buy |
200-day EMA: | 8.63 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 59.19 | Buy |
Chaikin Money Flow: | 114007 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.7 - 2) | Buy |
Bollinger Bands (100): | (1.46 - 2.32) | Buy |
BioXcel Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 2.02 while BTAI 8-day simple moving average is 1.97, which is a Buy signal.
-
The stock price of BTAI is 2.02 while BioXcel Therapeutics 20-day SMA is 1.85, which makes it a Buy.
-
BioXcel Therapeutics 50-day simple moving average is 1.66 while BTAI share price is 2.02, making it a Buy technically.
-
BTAI stock price is 2.02 and BioXcel Therapeutics 200-day simple moving average is 4.62, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
31
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $2.02. The Score for BTAI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
12.2M
Price in USD:
2.02
Share Volume:
276.9K
BioXcel Therapeutics 52-Week Range
52-Week High:
21.92
52-Week Low:
1.17
Sell
31
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 2.02 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 2.02 while BTAI 8-day exponential moving average is 1.97, which is a Buy signal.
-
The stock price of BTAI is 2.02 while BioXcel Therapeutics 20-day EMA is 1.87, which makes it a Buy.
-
BioXcel Therapeutics 50-day exponential moving average is 1.85 while BTAI share price is 2.02, making it a Buy technically.
-
BTAI stock price is 2.02 and BioXcel Therapeutics 200-day simple moving average is 8.63, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $4.64 per share, an increase next quarter of $2.48 per share, an increase this year of $22.65 per share, and a decrease next year of $1.94 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting BioXcel Therapeutics is a Buy
-
BioXcel Therapeutics Relative Strength Index (RSI) is 59.19, which suggest BioXcel Therapeutics is overbought
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.7 - 2), which suggest BioXcel Therapeutics is a Buy
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.46 - 2.32), which suggest BioXcel Therapeutics is a Buy
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.